RNA Leaders APAC 2025, Singapore

BioNTech Australia is participating in a panel discussion at the inaugural RNA Leaders APAC 2025 in Singapore on the topic, “Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region”.

The panellists will be

1. Exploring regional advancements in RNA technologies, including mRNA, siRNA, and circular RNA, and their potential to address unmet medical needs in Asia-Pacific.
2. Fostering cross-border collaboration between biotech companies, academic institutions, and regulatory bodies to accelerate R&D and clinical translation.
3. Navigating regional challenges and opportunities, from regulatory harmonization to talent development, in scaling RNA-based therapies across diverse healthcare ecosystems.

Moderator: Dr. Lisa Ooi - Assistant CEO, A*STAR

Panellists:

•  Dr Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
• Phoebe Dunn - CEO, mRNA Victoria
• Dr Mohamed ElSayed - Executive Director, Nucleic Acid Therapeutics Initiative (NATi)
• Dr JiaYee Lee, PhD - Director Strategy & Alliance, BioNTech Australia
• Professor Archa Fox - Director, Australian Centre for RNA Therapeutics in Cancer, RNA Innovation Foundry